A citation-based method for searching scientific literature

Mei-Chun Lin, Miao-Juei Huang, Chiung-Hui Liu, Tsung-Lin Yang, Min-Chuan Huang. Oral Oncol 2014
Times Cited: 55







List of co-cited articles
396 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.
Yao-Ming Wu, Chiung-Hui Liu, Rey-Heng Hu, Miao-Juei Huang, Jian-Jr Lee, Chi-Hau Chen, John Huang, Hong-Shiee Lai, Po-Huang Lee, Wen-Ming Hsu,[...]. Cancer Res 2011
73
38

Glycosylation in cancer: mechanisms and clinical implications.
Salomé S Pinho, Celso A Reis. Nat Rev Cancer 2015
27

Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family.
Eric P Bennett, Ulla Mandel, Henrik Clausen, Thomas A Gerken, Timothy A Fritz, Lawrence A Tabak. Glycobiology 2012
447
23

Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling.
Miao-Juei Huang, Rey-Heng Hu, Chih-Hsing Chou, Chia-Lang Hsu, Ya-Wen Liu, John Huang, Ji-Shiang Hung, I-Rue Lai, Hsueh-Fen Juan, Sung-Liang Yu,[...]. Oncotarget 2015
27
40

Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.
Zhi-Qiang Wang, Magdalena Bachvarova, Chantale Morin, Marie Plante, Jean Gregoire, Marie-Claude Renaud, Alexandra Sebastianelli, Dimcho Bachvarov. Oncotarget 2014
60
20

Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.
Jae-Hyun Park, Toshihiko Nishidate, Kyoko Kijima, Takao Ohashi, Kaoru Takegawa, Tomoko Fujikane, Koichi Hirata, Yusuke Nakamura, Toyomasa Katagiri. Cancer Res 2010
121
20

Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL.
Klaus W Wagner, Elizabeth A Punnoose, Thomas Januario, David A Lawrence, Robert M Pitti, Kate Lancaster, Dori Lee, Melissa von Goetz, Sharon Fong Yee, Klara Totpal,[...]. Nat Med 2007
431
18

All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases.
Kelly G Ten Hagen, Timothy A Fritz, Lawrence A Tabak. Glycobiology 2003
344
18

Glycosylation defining cancer malignancy: new wine in an old bottle.
Senitiroh Hakomori. Proc Natl Acad Sci U S A 2002
711
18

GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma.
Wan-Ling Ho, Chih-Hsing Chou, Yung-Ming Jeng, Meng-Yao Lu, Yung-Li Yang, Shiann-Tarng Jou, Dong-Tsamn Lin, Hsiu-Hao Chang, Kai-Hsin Lin, Wen-Ming Hsu,[...]. Oncotarget 2014
24
41

Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin.
Jae-Hyun Park, Toyomasa Katagiri, Suyoun Chung, Kyoko Kijima, Yusuke Nakamura. Neoplasia 2011
73
16

Mucin glycosylating enzyme GALNT2 suppresses malignancy in gastric adenocarcinoma by reducing MET phosphorylation.
Shin-Yun Liu, Chia-Tung Shun, Kuan-Yu Hung, Hsueh-Fen Juan, Chia-Lang Hsu, Min-Chuan Huang, I-Rue Lai. Oncotarget 2016
25
36


C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.
Yao-Ming Wu, Chiung-Hui Liu, Miao-Juei Huang, Hong-Shiee Lai, Po-Huang Lee, Rey-Heng Hu, Min-Chuan Huang. Cancer Res 2013
48
16


N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancers.
H Dosaka-Akita, I Kinoshita, K Yamazaki, H Izumi, T Itoh, H Katoh, M Nishimura, K Matsuo, Y Yamada, K Kohno. Br J Cancer 2002
34
20

GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
Tian Huanna, Zuo Tao, Wang Xiangfei, An Longfei, Xie Yuanyuan, Wang Jianhua, Zhang Cuifang, Jiao Manjing, Cao Wenjing, Qin Shaochuan,[...]. Mol Carcinog 2015
44
15

Glycosylation in cellular mechanisms of health and disease.
Kazuaki Ohtsubo, Jamey D Marth. Cell 2006
12

Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology.
Catharina Steentoft, Sergey Y Vakhrushev, Hiren J Joshi, Yun Kong, Malene B Vester-Christensen, Katrine T-B G Schjoldager, Kirstine Lavrsen, Sally Dabelsteen, Nis B Pedersen, Lara Marcos-Silva,[...]. EMBO J 2013
733
10

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
10

Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells.
Ying-Chih Liu, Hsin-Yung Yen, Chien-Yu Chen, Chein-Hung Chen, Ping-Fu Cheng, Yi-Hsiu Juan, Chung-Hsuan Chen, Kay-Hooi Khoo, Chong-Jen Yu, Pan-Chyr Yang,[...]. Proc Natl Acad Sci U S A 2011
236
10

Initiation of GalNAc-type O-glycosylation in the endoplasmic reticulum promotes cancer cell invasiveness.
David J Gill, Keit Min Tham, Joanne Chia, Shyi Chyi Wang, Catharina Steentoft, Henrik Clausen, Emilie A Bard-Chapeau, Frederic A Bard. Proc Natl Acad Sci U S A 2013
124
10

The Tn antigen-structural simplicity and biological complexity.
Tongzhong Ju, Vivianne I Otto, Richard D Cummings. Angew Chem Int Ed Engl 2011
202
10



C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2.
Ji-Shiang Hung, John Huang, Yo-Chuen Lin, Miao-Juei Huang, Po-Huang Lee, Hong-Shiee Lai, Jin-Tung Liang, Min-Chuan Huang. Oncotarget 2014
40
15

Protein glycosylation in cancer.
Sean R Stowell, Tongzhong Ju, Richard D Cummings. Annu Rev Pathol 2015
365
10

The O-glycosylating enzyme GALNT2 suppresses the malignancy of gastric adenocarcinoma by reducing EGFR activities.
Wan-Ting Hu, Chi-Chuan Yeh, Shin-Yun Liu, Min-Chuan Huang, I-Rue Lai. Am J Cancer Res 2018
10
60

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
10

Mucin O-glycosylating enzyme GALNT2 facilitates the malignant character of glioma by activating the EGFR/PI3K/Akt/mTOR axis.
Zhongzheng Sun, Hao Xue, Yan Wei, Chaochao Wang, Rui Yu, Chengwei Wang, Shaobo Wang, Jianye Xu, Mingyu Qian, Qinghu Meng,[...]. Clin Sci (Lond) 2019
15
40

Expression of uridine diphosphate N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase 3 in adenocarcinoma of the pancreas.
Shinji Yamamoto, Shoji Nakamori, Masanori Tsujie, Yuji Takahashi, Hiroaki Nagano, Keizo Dono, Koji Umeshita, Masato Sakon, Yasuhiko Tomita, Yoshihiko Hoshida,[...]. Pathobiology 2004
31
16


Prognostic significance of UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-3 (GalNAc-T3) expression in patients with gastric carcinoma.
Koji Onitsuka, Kazunori Shibao, Yoshifumi Nakayama, Noritaka Minagawa, Keiji Hirata, Hiroto Izumi, Ken-ichi Matsuo, Naoki Nagata, Kenji Kitazato, Kimitoshi Kohno,[...]. Cancer Sci 2003
32
15


Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival.
Z Li, S Yamada, S Inenaga, T Imamura, Y Wu, K-Y Wang, S Shimajiri, R Nakano, H Izumi, K Kohno,[...]. Br J Cancer 2011
55
9

Altered tumor-cell glycosylation promotes metastasis.
Irina Häuselmann, Lubor Borsig. Front Oncol 2014
222
9

Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process.
Leonardo Freire-de-Lima, Kirill Gelfenbeyn, Yao Ding, Ulla Mandel, Henrik Clausen, Kazuko Handa, Sen-Itiroh Hakomori. Proc Natl Acad Sci U S A 2011
85
9

Mucins in cancer: protection and control of the cell surface.
Michael A Hollingsworth, Benjamin J Swanson. Nat Rev Cancer 2004
9


GALNT4 predicts clinical outcome in patients with clear cell renal cell carcinoma.
Yidong Liu, Weisi Liu, Le Xu, Haiou Liu, Weijuan Zhang, Yu Zhu, Jiejie Xu, Jianxin Gu. J Urol 2014
10
50

miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis.
Avital Gaziel-Sovran, Miguel F Segura, Raffaella Di Micco, Mary K Collins, Douglas Hanniford, Eleazar Vega-Saenz de Miera, John F Rakus, John F Dankert, Shulian Shang, Robert S Kerbel,[...]. Cancer Cell 2011
260
9

The sweet and sour of cancer: glycans as novel therapeutic targets.
Mark M Fuster, Jeffrey D Esko. Nat Rev Cancer 2005
894
9

Core fucosylation regulates epidermal growth factor receptor-mediated intracellular signaling.
Xiangchun Wang, Jianguo Gu, Hideyuki Ihara, Eiji Miyoshi, Koichi Honke, Naoyuki Taniguchi. J Biol Chem 2006
216
9

Mucin-type O-glycosylation and its potential use in drug and vaccine development.
Mads Agervig Tarp, Henrik Clausen. Biochim Biophys Acta 2008
209
7

Antibody-based assay for N-deacetylase activity of heparan sulfate/heparin N-deacetylase/N-sulfotransferase (NDST): novel characteristics of NDST-1 and -2.
Jacob van den Born, Dagmar Sandback Pikas, Brenda J M Pisa, Inger Eriksson, Lena Kjellen, Jo H M Berden. Glycobiology 2003
66
7

Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells.
Jung-Jin Park, Jae Youn Yi, Yeung Bae Jin, Yoon-Jin Lee, Jae-Seon Lee, Yun-Sil Lee, Young-Gyu Ko, Minyoung Lee. Biochem Pharmacol 2012
84
7

Probing polypeptide GalNAc-transferase isoform substrate specificities by in vitro analysis.
Yun Kong, Hiren J Joshi, Katrine Ter-Borch Gram Schjoldager, Thomas Daugbjerg Madsen, Thomas A Gerken, Malene B Vester-Christensen, Hans H Wandall, Eric Paul Bennett, Steven B Levery, Sergey Y Vakhrushev,[...]. Glycobiology 2015
69
7

MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7.
Shireen Kahai, Shao-Chen Lee, Daniel Y Lee, Jennifer Yang, Minhui Li, Chia-Hui Wang, Zide Jiang, Yaou Zhang, Chun Peng, Burton B Yang. PLoS One 2009
134
7

Polypeptide N-acetylgalactosaminyltransferase 2 regulates cellular metastasis-associated behavior in gastric cancer.
Dong Hua, Li Shen, Lan Xu, Zhi Jiang, Yinghui Zhou, Aihuan Yue, Shitao Zou, Zhihong Cheng, Shiliang Wu. Int J Mol Med 2012
25
16

Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide galNAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinoma.
Kazunori Shibao, Hiroto Izumi, Yoshifumi Nakayama, Ryo Ohta, Naoki Nagata, Minoru Nomoto, Ken-ichi Matsuo, Yuji Yamada, Kenji Kitazato, Hideaki Itoh,[...]. Cancer 2002
60
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.